Hitachi Healthcare Americas introduces the “LISENDO 880,” New Premium 2D and 3D Cardiovascular Ultrasound System by Hitachi,” at ASE 2017
Cleveland, OH June 5, 2017 — Premium cardiac and vascular imaging rises to a new standard as Hitachi Healthcare Americas introduced its new premium 2D and 3D cardiovascular ultrasound system, the LISENDO 880, at the American Society of Echocardiography 2017 in Baltimore, Maryland on June 3rd, 2017.
Since their inception, today’s ultrasound systems have progressed to become essential medical devices for all levels of cardiovascular care. The LISENDO 880 is Hitachi’s new premium 2D and 3D diagnostic ultrasound solution for cardiologists that are redefining the vision for cardiac ultrasound by providing exceptional clinical performance with state-of-the-art features and analytics.
Hitachi released the world’s first diagnostic ultrasound system in 1960 and the first Color Doppler ultrasound system in 1983. Continuing this history of innovation, Hitachi introduced Vector Flow Mapping (VFM) analysis using ultrasound in 2012. Hitachi stands out as a company dedicated to providing unique solutions to echocardiography’s clinical challenges. The LISENDO 880 maintains Hitachi’s tradition of providing exceptionally innovative ultrasound for cardiovascular care.
The LISENDO 880 was developed to address the most important needs for cardiovascular imaging:
Pure Image Technology
The advanced architecture of the LISENDO 880 offers state of the art probe technology for 2D and 3D imaging, a high performance OLED display, premium image optimization parameters such as eFocus and Pure Symphonic Architecture to capture the subtlest of changes and produce the highest-quality “sound”.
The LISENDO 880 was designed to provide maximum scanning comfort, along with state-of-the-art technology to help you complete your exams more easily. The systems flexible positioning, including an adjustable panel height and a four-point articulating arm, support comfortable operation while the operation panel enables ergonomic function adjustment as a part of our intuitive user interface. The Smart Cardiac Measurements provide automated analysis to enhance examination efficiency. The LISENDO 880 delivers seamless workflow users expect in a premium ultrasound system.
The LISENDO 880 is Hitachi’s most advanced ultrasound system offering premium 2D and 3D cardiovascular applications. Features such as dynamic 3D evaluation, LVeFlow, Dual Gate Doppler, Eyeball EF, 2DTT, and FAM, provide solutions for the most difficult clinical challenges. Additionally, applications like VFM, eTracking and Wave Intensity move hemodynamic evaluations beyond the basics.
The LISENDO 880 maintains Hitachi’s tradition of providing exceptionally innovative ultrasound for cardiovascular care.
Hitachi Healthcare Americas Corporation, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Healthcare Business Unit, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at www.hitachi.com.